INMUNE BIO INC. Derivative Liability
INMUNE BIO INC. (INMB) had Derivative Liability of $0 as of 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2022-05-05
- 2022-03-31: Derivative Liability $0.00.
- 2021-12-31: Derivative Liability $0.00.
- 2021-09-30: Derivative Liability $244.00K.
- 2021-06-30: Derivative Liability $160.00K.
| Period end | Derivative Liability |
|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-03 |
| 2021-09-30 | $244.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $160.00K 10-Q · filed 2021-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |